The burden of primary diseases is substantial, demanding fresh therapeutic options. Stem cell therapies represent a remarkably promising avenue, offering the chance to repair damaged parenchymal tissue and enhance clinical outcomes. Currently, research focuses on several methods, including the delivery of adult regenerative units directly into the